AAAAAA

   
Results: 1-15 |
Results: 15

Authors: HIRSCHOWITZ J HITZEMANN R PISCANI K BURR G FRECSKA E CULLITON D MANN M CURTIS C
Citation: J. Hirschowitz et al., THE DOSE REDUCTION IN SCHIZOPHRENIA (DORIS) STUDY - A FINAL REPORT, Schizophrenia research, 23(1), 1997, pp. 31-43

Authors: VALLABHAJOSULA S HIRSCHOWITZ J MACHAC J
Citation: S. Vallabhajosula et al., EFFECT OF HALOPERIDOL DOSE ON IODINE-123-IBZM BRAIN SPECT IMAGING IN SCHIZOPHRENIC-PATIENTS, The Journal of nuclear medicine, 38(2), 1997, pp. 203-207

Authors: HIRSCHOWITZ J HITZEMANN R VALLABHAJOSULA S
Citation: J. Hirschowitz et al., SPECT STUDIES OF D-2 OCCUPANCY IN LOW-DOSE HALOPERIDOL TREATMENT, The American journal of psychiatry, 154(5), 1997, pp. 715-716

Authors: HARVEY PD DAVIDSON M WHITE L KEEFE RSE HIRSCHOWITZ J MOHS RC DAVIS KL
Citation: Pd. Harvey et al., EMPIRICAL-EVALUATION OF THE FACTORIAL STRUCTURE OF CLINICAL SYMPTOMS IN SCHIZOPHRENIA - EFFECTS OF TYPICAL NEUROLEPTICS ON THE BRIEF PSYCHIATRIC RATING-SCALE, Biological psychiatry, 40(8), 1996, pp. 755-760

Authors: KEEFE RSE FRESCKA E APTER SH DAVIDSON M MACALUSO JM HIRSCHOWITZ J DAVIS KL
Citation: Rse. Keefe et al., CLINICAL CHARACTERISTICS OF KRAEPELINIAN SCHIZOPHRENIA - REPLICATION AND EXTENSION OF PREVIOUS FINDINGS, The American journal of psychiatry, 153(6), 1996, pp. 806-811

Authors: GARVER DL SAUTTER F HIRSCHOWITZ J STEINBERG J GRIFFITH J
Citation: Dl. Garver et al., HETEROGENEITY OF THE PSYCHOSES .1. DOPAMINE PSYCHOSIS, Biological psychiatry, 37(9), 1995, pp. 681-682

Authors: GARVER DL SAUTTER F KNOLL J HIRSCHOWITZ J STEINBERG J KUMAR NG GRIFFITH J
Citation: Dl. Garver et al., HETEROGENEITY OF THE PSYCHOSES .2. NEURO-DEGENERATIVE PSYCHOSIS, Biological psychiatry, 37(9), 1995, pp. 682-682

Authors: STONE CK GARVER DL GRIFFITH J HIRSCHOWITZ J BENNETT J
Citation: Ck. Stone et al., FURTHER EVIDENCE OF A DOSE-RESPONSE THRESHOLD FOR HALOPERIDOL IN PSYCHOSIS, The American journal of psychiatry, 152(8), 1995, pp. 1210-1212

Authors: SCHEXNAYDER LW HIRSCHOWITZ J SAUTTER FJ GARVER DL
Citation: Lw. Schexnayder et al., PREDICTORS OF RESPONSE TO LITHIUM IN PATIENTS WITH PSYCHOSES, The American journal of psychiatry, 152(10), 1995, pp. 1511-1513

Authors: VALLABHAJOSULA S MACHAC J HIRSCHOWITZ J DACOSTA M LEE H LIPSZYC H MUZINIC M
Citation: S. Vallabhajosula et al., I-123 IBZM SPECT STUDIES OF DOPAMINE-RECEPTOR OCCUPANCY IN SCHIZOPHRENICS - EFFECT OF ANTIPSYCHOTIC DRUG-THERAPY, The Journal of nuclear medicine, 35(5), 1994, pp. 160000074-160000074

Authors: GARVER DL GRIFFITH J HIRSCHOWITZ J
Citation: Dl. Garver et al., MINIMUM EFFECTIVE DOSE OF HALOPERIDOL IN TREATMENT OF PSYCHOSES, Biological psychiatry, 35(9), 1994, pp. 667-667

Authors: HIRSCHOWITZ J VALLABHAJOSULA S INTRATOR J HITZEMANN R DACOSTA M MACHAC J
Citation: J. Hirschowitz et al., ANTIPSYCHOTIC DRUG-THERAPY IN SCHIZOPHRENICS - STUDIES OF RECEPTOR OCCUPANCY, Biological psychiatry, 35(9), 1994, pp. 691-691

Authors: APTER SH KEEFE RSE HIRSCHOWITZ J DAVIDSON M MACALUSO JM AMATO R DAVIS KL
Citation: Sh. Apter et al., LONGITUDINAL CLASSIFICATION IN SCHIZOPHRENIA - THE RELATIONSHIP BETWEEN KRAEPELINIAN AND DEFICIT SYNDROME SUBTYPOLOGIES, Biological psychiatry, 35(9), 1994, pp. 695-695

Authors: STERN RG KAHN RS HARVEY PD AMIN F APTER SH HIRSCHOWITZ J
Citation: Rg. Stern et al., EARLY RESPONSE TO HALOPERIDOL TREATMENT IN CHRONIC-SCHIZOPHRENIA, Schizophrenia research, 10(2), 1993, pp. 165-171

Authors: HIRSCHOWITZ J AYYALA M KRISHNAMOORTHY G GRIFFIN G FARRELL MP
Citation: J. Hirschowitz et al., A COMPARISON OF HOSPITAL CHARTING PRACTICES FOR PATIENTS WITH SCHIZOPHRENIA, Hospital & community psychiatry, 43(4), 1992, pp. 392-393
Risultati: 1-15 |